It is well established that maternal smoking during pregnancy is a leading
preventable cause of low birth weight and prematurity. Less appreciated is
that maternal smoking during pregnancy is also associated with alterations
in pulmonary function at birth and greater incidence of respiratory illness
es after birth. To determine if this is the direct result of nicotine inter
acting with nicotinic cholinergic receptors (nAChRs) during lung developmen
t, rhesus monkeys were treated with 1 mg/kg/day of nicotine from days 26 to
134 of pregnancy. Nicotine administration caused lung hypoplasia and reduc
ed surface complexity of developing alveoli. Immunohistochemistry and in si
tu alpha-bungarotoxin (alpha BGT) binding showed that alpha 7 nAChRs are pr
esent in the developing lung in airway epithelial cells, cells surrounding
large airways and blood vessels, alveolar type II cells, free alveolar macr
ophages, and pulmonary neuroendocrine cells (PNEC). As detected both by imm
unohistochemistry and by alpha BGT binding, nicotine administration markedl
y increased alpha 7 receptor subunit expression and binding in the fetal lu
ng. Correlating with areas of increased alpha 7 expression, collagen expres
sion surrounding large airways and vessels was significantly increased. Nic
otine also significantly increased numbers of type II cells and neuroendocr
ine cells in neuroepithelial bodies. These findings demonstrate that nicoti
ne can alter fetal monkey lung development by crossing the placenta to inte
ract directly with nicotinic receptors on non-neuronal cells in the develop
ing lung, and that similar effects likely occur in human infants whose moth
ers smoke during pregnancy.